Vaccine Development

More "Orphan" Vaccines Needed for Rare Diseases

Published in Vaccine Weekly, January 12th, 2000

Drug companies may need additional incentives if they are to develop vaccines for rare diseases, according to an article in the November-December 1999 issue of Emerging Infectious Diseases, the peer-reviewed journal of the US Centers for Disease Control and Prevention, which tracks new and reemerging infectious diseases worldwide.

Orphan vaccines are vaccines for diseases that are rare or occur only in limited regions of the world. Vaccines for diseases that cannot be prevented or cured by other means are urgently needed for humanitarian reasons, but the vaccines are not cost-effective to produce and market. As a result, only a few are manufactured and reach the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry